Reuters logo
BRIEF-Sanofi CEO comments Q2 results on conference call
July 31, 2014 / 5:36 AM / 3 years ago

BRIEF-Sanofi CEO comments Q2 results on conference call

July 31 (Reuters) - Sanofi SA Chief Executive Chris Viehbacher tells reporters: * Expects vaccines business to return to double-digit growth in H2 * “Could imagine” U.S. launch of cholesterol drug alirocumab in H2 2015,

ahead or at same time as Amgen Inc * “Everybody is talking to everybody” on what to do with mature drug portfolios

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below